INVO Fertility, Inc. (IVF) Balance Sheet

The persistent inability to maintain a current ratio above unity suggests that the company is operating with a structural liquidity deficit. Investors should monitor the cash runway closely, as the current cash position of $4.9M in 2026Q1 remains insufficient to support the company's high burn rate and ongoing operational requirements.

The erratic nature of the leverage metrics suggests that the company's debt profile is highly sensitive to equity market conditions and the need for periodic refinancing. This instability warrants further investigation into the terms of existing debt agreements and the potential for future covenant breaches if operational losses continue to erode equity.

The persistent negative trajectory of retained earnings indicates that the core business model has failed to generate sufficient returns to offset operating expenses. This trend suggests that shareholders may face continued dilution as the company attempts to bridge the gap between its current clinical-stage investments and operational breakeven.